-->

Company Registry

Halimed Pharmaceuticals Inc
Profile last edited on: 8/20/2015

Biotechnology company developing a pipeline of drugs for affective disorders
Year Founded
2009
First SBIR Year
N/A
Latest SBIR Award
2015
Program Status
Inactive

WikiProfile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

475-A East Bay Street
Charleston, SC 29403
   (919) 260-5595
   jim254@aol.com
   N/A
Multiple Locations:   
Congressional District:   06
County:   Charleston

Public Profile

Halimed Pharmaceuticals Inc. is a biotechnology company developing a pipeline of drugs for affective disorders. The company's technology is centered on a proprietary peptide modification chemistry platform and intellectual properties of a portfolio of non-natural amino acid analogs of arginine (Arg) and lysine (Lys) that, when incorporated into biologically active peptides, improves their overall pharmacological profile

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
---
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  James R McNab -- CEO

SBIR firms in the news

There are no news available.